[HTML][HTML] Race, nativity, and sex disparities in human papillomavirus vaccination among young adults in the USA
Research has demonstrated that the human papillomavirus (HPV) vaccine is a safe and
effective way to decrease HPV-related cervical cancers; however, the vaccination rate in the …
effective way to decrease HPV-related cervical cancers; however, the vaccination rate in the …
[HTML][HTML] Ten-year follow-up of 9-valent human papillomavirus vaccine: immunogenicity, effectiveness, and safety
J Restrepo, T Herrera, R Samakoses, JC Reina… - …, 2023 - publications.aap.org
Video Abstract BACKGROUND AND OBJECTIVES The 9-valent human papillomavirus
(9vHPV) vaccine Phase III immunogenicity study in 9-to 15-year-old boys and girls was …
(9vHPV) vaccine Phase III immunogenicity study in 9-to 15-year-old boys and girls was …
Correlates of human papillomavirus (HPV) vaccination initiation and completion among 18–26 year olds in the United States
E Adjei Boakye, D Lew, M Muthukrishnan… - Human Vaccines & …, 2018 - Taylor & Francis
Purpose: To examine correlates of HPV vaccination uptake in a nationally representative
sample of 18–26-year-old adults. Methods: Young adults aged 18–26 years were identified …
sample of 18–26-year-old adults. Methods: Young adults aged 18–26 years were identified …
Human papillomavirus vaccine uptake among males 11–26 years in United States: Findings from the National Health and Nutrition Examination Survey, 2011–2012
D Pierre-Victor, S Mukherjee, R Bahelah… - Vaccine, 2014 - Elsevier
Anogenital human papillomavirus (HPV) infection is the leading sexually transmitted
infection in the United States. In October 2011, the quadrivalent HPV vaccine (HPV4) was …
infection in the United States. In October 2011, the quadrivalent HPV vaccine (HPV4) was …
Age-specific human papillomavirus antibody and deoxyribonucleic acid prevalence: a global review
SM Tiggelaar, MJ Lin, RP Viscidi, J Ji… - Journal of Adolescent …, 2012 - Elsevier
PURPOSE: Global data on human papillomavirus (HPV) serological and deoxyribonucleic
acid (DNA) prevalence are essential to optimize HPV prophylactic vaccination strategies …
acid (DNA) prevalence are essential to optimize HPV prophylactic vaccination strategies …
Role and uptake of human papillomavirus vaccine in adolescent health in the United States
Both the prophylactic human papillomavirus (HPV) vaccines, Gardasil® and Cervarix®, are
licensed for the prevention of cervical cancer in females, and Gardasil is also licensed for …
licensed for the prevention of cervical cancer in females, and Gardasil is also licensed for …
Health disparities in human papillomavirus vaccine coverage: Trends analysis from the National Immunization Survey–Teen, 2008–2011
RA Bednarczyk, EA Curran… - Clinical infectious …, 2014 - academic.oup.com
Adolescent uptake of human papillomavirus (HPV) vaccine remains low. We evaluated HPV
vaccine uptake patterns over 2008–2011 by race/ethnicity, poverty status, and the …
vaccine uptake patterns over 2008–2011 by race/ethnicity, poverty status, and the …
Trends in HPV vaccine initiation among adolescent females in North Carolina, 2008–2010
Background: To better target future immunization efforts, we assessed trends and disparities
in human papillomavirus (HPV) vaccine initiation among female adolescents in North …
in human papillomavirus (HPV) vaccine initiation among female adolescents in North …
Correlates of human papillomavirus vaccine coverage: a state-level analysis
Background We tested the hypothesis that states with higher rates of cancers associated
with human papillomavirus (HPV) would have lower HPV vaccine coverage. Methods We …
with human papillomavirus (HPV) would have lower HPV vaccine coverage. Methods We …
Reduction of HPV infections through vaccination among at-risk urban adolescents
INTRODUCTION: Human papillomavirus (HPV) vaccine trials have demonstrated high
efficacy in preventing HPV infections and HPV related disease in females ages 16–26 …
efficacy in preventing HPV infections and HPV related disease in females ages 16–26 …